Abstract Title

Cyanotoxin Degrading Lake Bacteria Significantly Alleviate Microcystin-LR Induced Hepatotoxicity in Both In Vitro and In Vivo Models

Start Date

27-5-2022 11:45 AM

End Date

27-5-2022 12:00 PM

Abstract

Our recent reports have shown that exposure to microcystin-LR (MC-LR) exacerbates the development of pre-existing liver and inflammatory bowel disease as well as alters gut microbiota that may significantly impact development of hepatotoxicity. We have isolated naturally occurring novel MC-LR degrading bacteria from Lake Erie, OH and hypothesized that they may alleviate MC-LR toxicity. qPCR analysis for markers of hepatotoxicity and inflammation in both in vivo and in vitro (using human Hep3B hepatocytes) settings showed significant downregulation in their expression in presence of MC degrading bacteria compared to the untreated groups. LC-MS analysis of the 24-hour urine samples in an in vivo setting with age matched Balb/c female mice that were pre-treated with the bacteria prior to 500 μg/kg MC-LR exposure for 24 hrs revealed significant reduction in urine MC-LR levels of mice pre-treated with MC-LR degrading bacteria as compared to the control group. Analysis of genes related to MC-LR induced apoptosis, DNA damage, ER stress, and fatty acid metabolism were also significantly downregulated in mice treated with MC degrading bacteria compared to control mice exposed to the toxin alone. These results suggest a potential novel therapeutic approach that can be developed for MC-LR induced toxicity.

This document is currently not available here.

COinS
 
May 27th, 11:45 AM May 27th, 12:00 PM

Cyanotoxin Degrading Lake Bacteria Significantly Alleviate Microcystin-LR Induced Hepatotoxicity in Both In Vitro and In Vivo Models

Our recent reports have shown that exposure to microcystin-LR (MC-LR) exacerbates the development of pre-existing liver and inflammatory bowel disease as well as alters gut microbiota that may significantly impact development of hepatotoxicity. We have isolated naturally occurring novel MC-LR degrading bacteria from Lake Erie, OH and hypothesized that they may alleviate MC-LR toxicity. qPCR analysis for markers of hepatotoxicity and inflammation in both in vivo and in vitro (using human Hep3B hepatocytes) settings showed significant downregulation in their expression in presence of MC degrading bacteria compared to the untreated groups. LC-MS analysis of the 24-hour urine samples in an in vivo setting with age matched Balb/c female mice that were pre-treated with the bacteria prior to 500 μg/kg MC-LR exposure for 24 hrs revealed significant reduction in urine MC-LR levels of mice pre-treated with MC-LR degrading bacteria as compared to the control group. Analysis of genes related to MC-LR induced apoptosis, DNA damage, ER stress, and fatty acid metabolism were also significantly downregulated in mice treated with MC degrading bacteria compared to control mice exposed to the toxin alone. These results suggest a potential novel therapeutic approach that can be developed for MC-LR induced toxicity.